CLINICAL_TRIALS
trial_result
· 2023-09-06
Clinical Trial Update: Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome [Phase 3]
Summary
Phase 3 clinical trial comparing vortioxetine to other antidepressants with pregabalin augmentation for Burning Mouth Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Federico II University | Conditions: Burning Mouth Syndrome | Phase 3 | Status: UNKNOWN